Similar articles

• Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.

  Roselli A, Hayes JD, Seidner R, Marchione V, Snyder CM, Mayes K, Stiernberg CM, Milgram L. Roselli A, et al. Manag Care. 2001 Feb;10(2 Suppl):17-21. Manag Care. 2001. PMID: 11729404 No abstract available.
• Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.

  Blonde L, Sandberg MI. Blonde L, et al. Diabetes Technol Ther. 2000 Autumn;2(3):479-80. doi: 10.1089/15209150050194350. Diabetes Technol Ther. 2000. PMID: 11467351 No abstract available.
• Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.

  Medina Santillán R, Reyes-García G, Mateos-García E. Medina Santillán R, et al. Proc West Pharmacol Soc. 2002;45:137-8. Proc West Pharmacol Soc. 2002. PMID: 12434558 Clinical Trial. No abstract available.
• Glyburide/metformin HCl clinical overview.

  Seymour A. Seymour A. Manag Care. 2001 Feb;10(2 Suppl):11-6. Manag Care. 2001. PMID: 11729403 Review. No abstract available.
• Combination agents for diabetes.

  Samuel J, Rochester CD. Samuel J, et al. Adv Nurse Pract. 2003 Jun;11(6):22-4. Adv Nurse Pract. 2003. PMID: 12807051 Review. No abstract available.